Pfizer (NYSE: PFE) reported first-quarter 2021 financial results ahead of the regular market hours on Tuesday. The pharmaceutical giant reported Q1 revenue
Pfizer (PFE) reports Q1 EPS of 93 cents: Infographic
Pfizer (NYSE: PFE) reported first-quarter 2021 financial results ahead of the regular market hours on Tuesday. The pharmaceutical giant reported Q1 revenue
Over the past few months, Trxade Group (NASDAQ: MEDS) has been busy in its development lab, creating tools that could enable the
PetMed Express, Inc. (NASDAQ: PETS) Q4 2020 earnings call dated May. 03, 2021 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer and Treasurer
AbbVie (NYSE: ABBV) today reported its first quarter financial results for the period ended March 31, 2021. Net income for the first
AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant's flagship product
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Michael Partridge -- Senior Vice President of Investor Relations
Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Traci McCarty -- Vice President of Investor Relations Jean-Jacques
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its first-quarter 2021 earnings today after the closing bell. The revenue increased by 16%
Vertex Pharmaceuticals (NASDAQ: VRTX) reported first-quarter 2021 financial results after the regular market hours on Thursday. The pharmaceutical firm reported Q1 revenue
Merck & Co., Inc. (NYSE: MRK) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Kenneth
Abiomed, Inc. (NASDAQ: ABMD) Q4 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Bristol-Myers Squibb Company (NYSE: BMY) reported first quarter 2021 earnings results today. Revenues increased 3% year-over-year to $11.1 billion. Net earnings attributable
GlaxoSmithKline plc. ( LON: GSK) Q1 2021 earnings call dated Apr. 28, 2021 Corporate Participants: Iain Mackay -- Chief Financial Officer Dame Emma Walmsley -- Chief
Boston Scientific Corp. (NYSE: BSX) Q1 2021 earnings call dated Apr. 28, 2021 Corporate Participants: Susie Lisa -- Vice President, Investor Relations Michael F.
Teva Pharmaceuticals’ (NYSE: TEVA) reported first-quarter 2021 results today before the opening bell. The company dropped its revenue by 9% to $3.98
Amgen Inc. (NASDAQ: AMGN) Q1 2021 earnings call dated Apr. 27, 2021 Corporate Participants: Arvind Sood -- Vice President, Investor Relations Robert A. Bradway -- Chairman
Eli Lilly and Company (NYSE: LLY) Q1 2021 earnings call dated Apr. 27, 2021 Corporate Participants: Kevin Hern -- Vice President, Investor Relations David A.
Trxade Group Inc. (NASDAQ: MEDS) Q1 2021 earnings call dated Apr. 26, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade (NASDAQ: MEDS) on Monday posted a 39% increase in first-quarter revenues to $3.1 million due to higher sales in the Integra
Koninklijke Philips N.V. (NYSE: PHG) Q1 2021 earnings call dated Apr. 26, 2021 Corporate Participants: Leandro Mazzoni -- Head of Investor Relations Frans van
IQVIA Holdings Inc. (NYSE: IQV) Q1 2021 earnings call dated Apr. 22, 2021. Corporate Participants: Andrew Markwick -- Senior Vice President, Investor